Eli Lilly shares are trading lower Friday, among other GLP-1 drug manufacturers, following Trump's comments that fat-loss ...
Since then, supply has returned thanks to Lilly's investments in manufacturing and a move to also offer Zepbound, previously ...
CMS Administrator Mehmet Oz clarified that a deal has not yet been sealed with the manufacturer of semaglutide, Novo Nordisk, ...
Peter Marks, the former top vaccine regulator at the U.S. Food and Drug Administration, has joined Eli Lilly, STAT News ...
Eli Lilly holds the lead position in the weight management market right now. But Viking Therapeutics is working on a ...
Eli Lilly stock has recovered resoundingly, outperforming the S&P 500, Novo Nordisk, and healthcare peers after a period of ...
Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an ...
Zions Bancorp trades higher following a drop of 13% in the previous session on bank loan worries, while American Express ...
Eli Lilly and Company's strong Phase 3 diabetes drug results boost its GLP-1 franchise. Click for my updated look at LLY ...